Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.11.23 | Molecure - Q323 report highlights clinical progress | 340 | Edison Investment Research | Molecure has released its Q323 report, providing an update on its clinical development activities, particularly around its oral, first-in-class inhibitor, OATD-01. Following the acceptance of the Investigational... ► Artikel lesen | |
06.11.23 | Supermarket Income REIT - Progressive dividend policy remains in place | 327 | Edison Investment Research | With its focus on high-quality omnichannel supermarkets, Supermarket Income REIT (SUPR) is very well positioned to benefit from strong growth trends in the grocery sector, supportive of its income proposition... ► Artikel lesen | |
06.11.23 | Oryzon Genomics - Q323 recap ahead of key clinical stages | 546 | Edison Investment Research | Oryzon's Q323 results recapped the clinical progression across its drug development pipeline. The company continues to develop therapies that address unmet needs related to the central nervous system... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 325 |
EVOTEC | 291 |
TUI | 209 |
NVIDIA | 176 |
DEUTSCHE BANK | 168 |
BAYER | 153 |
PLUG POWER | 143 |
NEL | 133 |
RHEINMETALL | 127 |
BARRICK GOLD | 109 |
SIEMENS ENERGY | 109 |
COMMERZBANK | 105 |
TESLA | 101 |
BASF | 100 |
VOLKSWAGEN | 92 |
RWE | 88 |
BYD | 86 |
DEUTSCHE LUFTHANSA | 83 |
ALLIANZ | 82 |
RENK GROUP | 78 |
MERCEDES-BENZ | 77 |
DEUTSCHE TELEKOM | 75 |
HEIDELBERGER DRUCK | 74 |
ALIBABA | 70 |
E.ON | 69 |